Suppr超能文献

腺嘌呤诱导大鼠慢性肾脏和心血管损伤。

Adenine-induced chronic kidney and cardiovascular damage in rats.

作者信息

Diwan Vishal, Mistry Anand, Gobe Glenda, Brown Lindsay

机构信息

School of Biomedical Science, The University of Queensland, Australia; Centre for Kidney Disease Research, School of Medicine, The University of Queensland, Australia.

Department of Biological and Physical Sciences, The University of Southern Queensland, Australia.

出版信息

J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):197-207. doi: 10.1016/j.vascn.2013.05.006. Epub 2013 May 31.

Abstract

BACKGROUND

The incidence of human chronic kidney failure with associated cardiovascular disease is increasing. Kidney damage can be induced in rats by chronic dietary adenine intake. We have used this intervention to investigate the development of concurrent kidney and cardiovascular injury.

METHODS

Dose-ranging studies were undertaken on male Wistar rats by feeding with adenine (0.075%, 0.25%, 0.5% or 0.75%) for up to 16weeks. 0.075% adenine produced minimal changes while 0.5% or 0.75% adenine produced marked kidney damage; 0.25% adenine was chosen for further studies since it produced moderate kidney and cardiovascular damage. In rats fed 0.25% adenine, renal function (blood urea nitrogen (BUN), plasma creatinine, and their clearances; plasma uric acid; proteinuria); renal structure (collagen, apoptosis, inflammation, glomerulopathy); and protein expression of markers for oxidative stress (HO-1), fibrosis (TGF-β, α-SMA) and inflammation (TNF-α, NF-κB p52, NF-κB p50, PLA2 and ED1) were measured, along with cardiovascular parameters (blood pressure, left ventricular stiffness, vascular responses). Allopurinol (25mg/kg/day, final 8weeks only) was administered to determine the role of uric acid.

RESULTS

0.25% adenine diet induced characteristics of human chronic kidney disease at 16weeks including increased BUN (0.25% adenine 56.5±5.4*; control 6.2±0.6mmol/L; =p<0.05) and plasma creatinine (0.25% adenine 268±23; control 41.9±2.8μg/L), decreased BUN and creatinine clearances; proteinuria; increased chronic inflammation as macrophage and myofibroblast infiltration, increased collagen deposition, tubular atrophy, apoptosis, and TNF-α and TGF-β expression; glomerulopathy as increased podocyte desmin expression; increased HO-1 expression; and increased plasma uric acid. Cardiovascular changes included increased ventricular fibrosis, systolic blood pressure and left ventricular stiffness, and impaired vascular responses. Allopurinol decreased plasma uric acid concentrations and reversed the adenine-induced kidney and cardiovascular changes.

CONCLUSION

Administration of 0.25% adenine to rats induced chronic kidney and cardiovascular disease. Increased uric acid production is the most likely cause since allopurinol attenuated this damage.

摘要

背景

伴有心血管疾病的人类慢性肾衰竭发病率正在上升。长期摄入腺嘌呤可诱导大鼠发生肾损伤。我们利用这种干预措施来研究同时发生的肾脏和心血管损伤的发展情况。

方法

对雄性Wistar大鼠进行剂量范围研究,通过喂食腺嘌呤(0.075%、0.25%、0.5%或0.75%)长达16周。0.075%腺嘌呤产生的变化最小,而0.5%或0.75%腺嘌呤产生明显的肾损伤;选择0.25%腺嘌呤进行进一步研究,因为它产生中度的肾脏和心血管损伤。在喂食0.25%腺嘌呤的大鼠中,测量肾功能(血尿素氮(BUN)、血浆肌酐及其清除率;血浆尿酸;蛋白尿);肾脏结构(胶原蛋白、细胞凋亡、炎症、肾小球病变);以及氧化应激标志物(HO-1)、纤维化标志物(TGF-β、α-SMA)和炎症标志物(TNF-α、NF-κB p52、NF-κB p50、PLA2和ED1)的蛋白表达,同时测量心血管参数(血压、左心室僵硬度、血管反应)。给予别嘌醇(25mg/kg/天,仅在最后8周)以确定尿酸的作用。

结果

0.25%腺嘌呤饮食在16周时诱导出人类慢性肾病的特征,包括BUN升高(0.25%腺嘌呤组56.5±5.4*;对照组6.2±0.6mmol/L;=p<0.05)和血浆肌酐升高(0.25%腺嘌呤组268±23;对照组41.9±2.8μg/L),BUN和肌酐清除率降低;蛋白尿;慢性炎症增加,表现为巨噬细胞和成肌纤维细胞浸润、胶原蛋白沉积增加、肾小管萎缩、细胞凋亡以及TNF-α和TGF-β表达增加;肾小球病变表现为足细胞结蛋白表达增加;HO-1表达增加;以及血浆尿酸升高。心血管变化包括心室纤维化增加、收缩压和左心室僵硬度增加以及血管反应受损。别嘌醇降低了血浆尿酸浓度,并逆转了腺嘌呤诱导的肾脏和心血管变化。

结论

给大鼠喂食0.25%腺嘌呤可诱导慢性肾脏和心血管疾病。尿酸生成增加最可能是原因,因为别嘌醇减轻了这种损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验